These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 291948)

  • 61. Early effect of interferon on mouse leukemia cells cultivated in a chemostat.
    Tovey M; Brouty-Boyé D; Gresser I
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2265-9. PubMed ID: 1056030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibitory effect of interferon on the growth of spontaneous mammary tumors in mice.
    De Clercq E; Zhang ZX; Huygen K; Leyten R
    J Natl Cancer Inst; 1982 Sep; 69(3):653-7. PubMed ID: 6180210
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.
    Borden EC; Hogan TF; Voelkel JG
    Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interferon action: induction of specific proteins in mouse and human cells by homologous interferons.
    Gupta SL; Rubin BY; Holmes SL
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4817-21. PubMed ID: 291901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Production of inhibitors of interferon action by cell lines sensitive and insensitive to the antiviral action of interferon].
    Khesin IaE; Parfenov VV; Amchenkova AM; Narovlianskiĭ AN; Tkach TA
    Vopr Virusol; 1985; 30(5):584-6. PubMed ID: 2416134
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leukemic cells sensitive or resistant to beta-interferon have identical ganglioside patterns.
    MacDonald HS; Elconin H; Ankel H
    FEBS Lett; 1982 May; 141(2):267-70. PubMed ID: 6178622
    [No Abstract]   [Full Text] [Related]  

  • 69. Increased survival in mice inoculated with tumor cells and treated with interferon preparations.
    Gresser I; Bourali C; Lévy JP; Fontaine-Brouty-Boyé D; Thomas MT
    Proc Natl Acad Sci U S A; 1969 May; 63(1):51-7. PubMed ID: 5257966
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ingestion of bacteria by antibody-coated Ehrlich ascites tumor cells mediated by protein A.
    Seki K; Sasaki H; Nishihara S; Suzuki T; Masuda S
    Microbiol Immunol; 1986; 30(8):819-25. PubMed ID: 3537642
    [No Abstract]   [Full Text] [Related]  

  • 71. [Inhibition in vitro of multiplication of L 1210 murine leukemia cells by interferon preparations].
    Fontaine-Brouty-Boyé D; Gresser I; Macieira-Coelho A; Rosenfeld C; Thomas MT
    C R Acad Hebd Seances Acad Sci D; 1969; 269(3):406-8. PubMed ID: 4980277
    [No Abstract]   [Full Text] [Related]  

  • 72. Interferon induces pulmonary cysts in A2G mice.
    Woodrow D; Moss J; Gresser I
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7937-40. PubMed ID: 6595668
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemical modifications of tyrosyl residue(s) and action of human-fibroblast interferon.
    Berthold W; Tan C; Tan YH
    Eur J Biochem; 1978 Jun; 87(2):367-70. PubMed ID: 678325
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 75. A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
    Suarez-Kelly LP; Levine KM; Olencki TE; Del Campo SEM; Streacker EA; Brooks TR; Karpa VI; Markowitz J; Bingman AK; Geyer SM; Kendra KL; Carson WE
    Cancer Immunol Immunother; 2019 Apr; 68(4):619-629. PubMed ID: 30725205
    [No Abstract]   [Full Text] [Related]  

  • 76. Anti-inflammatory properties of Type I interferons.
    Billiau A
    Antiviral Res; 2006 Sep; 71(2-3):108-16. PubMed ID: 16626815
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytokine research: the interferon paradigm.
    Morris A; Zvetkova I
    J Clin Pathol; 1997 Aug; 50(8):635-9. PubMed ID: 9301545
    [No Abstract]   [Full Text] [Related]  

  • 78. Inhibition of wound healing in mice by local interferon alpha/beta injection.
    Stout AJ; Gresser I; Thompson WD
    Int J Exp Pathol; 1993 Feb; 74(1):79-85. PubMed ID: 7682435
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human polymorphonuclear neutrophil functions are unaffected by human interferon-alpha 2.
    Farr B; Gwaltney JM; Hayden FG; Mandell GL
    Infect Immun; 1983 Dec; 42(3):1195-7. PubMed ID: 6642666
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Marked reduction of ANAE reactivity of T cells in the lymphoid tissues of monkeys treated with multiple high doses of human beta interferon.
    Ohtaki S; Tatsumi M; Kohase M; Yamazaki S
    Br J Exp Pathol; 1983 Dec; 64(6):638-43. PubMed ID: 6607063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.